Novo Seeds
Denmarknovoholdings.dk
Overview
Novo Seeds is the early-stage investment arm of Novo Holdings, focusing on building new companies based on breakthrough scientific discoveries. They identify, build, and invest in innovative Nordic startup companies founded on strong science, with the ultimate goal of developing products that can transform patient treatment. Novo Seeds is the leading early stage life-science investor in Scandinavia. The fund provides capital, knowledge, and network to help promising life science projects grow.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Biosyntia | Jul 2022 | Series B | Co-investor |
| NorthSea Therapeutics | Dec 2021 | Series C | Co-investor |
| Hemab | Jul 2021 | Series A | Co-investor |
| Adcendo | Apr 2021 | Series A | Lead |
| Minervax | Dec 2020 | Series B | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.